Skip to main content
logo
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.2540
-0.0044 (-1.70%)
At close: Aug 24, 2026, 4:00 PM EDT
0.2540
0.00 (0.00%)
After-hours: Aug 24, 2026, 6:30 PM EDT

AIM ImmunoTech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.10.090.170.20.140.14
Revenue Growth
-21.49%-48.23%-15.84%43.26%4.44%-17.18%
Gross Profit
-0.02-0.040.140.160.14-0.72
Operating Income
-11.14-11.66-19.77-31.92-19.92-17.06
Net Income
-14.27-13.96-17.32-28.96-19.45-19.13
Earnings Per Share
-2.14-8.62-30.92-59.55-40.43-40.36
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.963.053.9813.0734.1948.27
Total Debt
3.924.92.940.720.840.15
Net Cash (Debt)
6.04-1.851.0412.3533.3548.12
Net Cash Growth
---91.61%-62.97%-30.69%-7.63%
Net Cash Per Share
0.91-1.141.8525.4069.35101.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.37-10.96-14.89-21.27-16.11-13.97
Capital Expenditures
---0.02--0.09-0.04
Free Cash Flow
-14.37-10.96-14.91-21.27-16.19-14.01
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-23.16%-45.45%81.77%79.21%100.00%-
Operating Margin
-11724.21%-13254.54%-11630.59%-15800.00%-14129.79%-12636.30%
Pretax Margin
-15021.05%-15861.36%-10188.24%-14337.62%-13790.78%-14168.15%
Profit Margin
-15021.05%-15861.36%-10188.24%-14337.62%-13790.78%-14168.15%
FCF Margin
-15130.53%-12451.14%-8768.24%-10528.22%-11485.11%-10374.81%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
82.2736.6474.28106.36106.36326.08